Titan Pharmaceuticals Inc
NASDAQ:TTNP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Titan Pharmaceuticals Inc
NASDAQ:TTNP
|
US |
|
F
|
Forafric Global PLC
NASDAQ:AFRI
|
GI |
|
P
|
Phoenix Holdings Ltd
TASE:PHOE
|
IL |
|
M
|
Minera Frisco SAB de CV
OTC:MFRVF
|
MX |
|
Metasphere Labs Inc
OTC:LABZD
|
CA |
|
M
|
Megureit Israel Ltd
TASE:MGRT
|
IL |
|
Chrysalis Investments Ltd
LSE:CHRY
|
GG |
|
G
|
GlobalBlock Digital Asset Trading Ltd
XTSX:BLOK
|
CA |
|
I
|
Inmobiliaria Sixterra SA
SGO:SIXTERRA
|
CL |
|
Aurora Mobile Ltd
NASDAQ:JG
|
CN |
|
Applied Therapeutics Inc
NASDAQ:APLT
|
US |
|
Bigtincan Holdings Ltd
ASX:BTH
|
AU |
|
B
|
BEML Land Assets Ltd
NSE:BLAL
|
IN |
|
Doctor Care Anywhere Group PLC
ASX:DOC
|
UK |
|
M
|
MUI Properties Bhd
KLSE:MUIPROP
|
MY |
|
K
|
KCG Corporation PCL
SET:KCG
|
TH |
|
Gelstat Corp
OTC:GSAC
|
US |
|
Monalisa Co Ltd
KRX:012690
|
KR |
Bankruptcy Probability
Titan Pharmaceuticals Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Titan Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Titan Pharmaceuticals Inc
NASDAQ:TTNP
|
6.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Titan Pharmaceuticals Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Titan Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.
